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Unbiased genetic analysis of experimental autoimmune encephalomyelitis (EAE) can provide insights into the pathogenesis of multiple
sclerosis. To date five genome-wide scans using F2 crosses between different inbred rats have been performed with the aim of defining EAE-
regulating quantitative trait loci (QTLs) as the starting point for identification of the underlying genes. We here report the first combined-cross
analysis of three F2 crosses previously performed in our group. The majority of QTLs was shared between the different strain combinations and
was therefore reproduced by the combined-cross analysis. Consequently, combined-cross analysis improved the power to detect QTLs with
modest effects and narrowed QTL confidence intervals. The findings also demonstrate a lack of power in previous F2 crosses and encourage
future use of larger populations. Moreover, the allelic states of shared QTLs could be established, thus providing critical information for narrowing
QTLs and identifying the key polymorphism by subsequent haplotype analysis.
© 2006 Elsevier Inc. All rights reserved.Keywords: QTL mapping; Combined-cross analysis; EAE; MS; Inbred strain; Rodent; RatUnbiased identification of genes that regulate disease is a
powerful phenotype-driven approach to define primary disease
mechanisms, which in turn may lead to the design of more
rational and effective therapeutic strategies and/or prevention.
Our interest is in the field of multiple sclerosis (MS). In this
disease, linkage analyses in large numbers of families have
failed to reveal any significant gene region apart from the HLA,
as recently demonstrated in a SNP-based whole genome scan
[1]. We have concentrated our genetic analyses on chronic
forms of experimental autoimmune encephalomyelitis (EAE)
under the assumption that gene polymorphisms critically
involved in this experimental disease can yield mechanisms
relevant and accessible for drug targeting also for humans. It
may furthermore identify candidate genes to be studied by more
powerful association studies in large cohorts of MS cases and
controls. With these aims genetic analyses of EAE were
initiated in the 1990s [2–8]. Both MS and EAE are complex
diseases determined by multiple genetic and environmental⁎ Corresponding author. Fax: +46 8 51776248.
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doi:10.1016/j.ygeno.2006.08.013factors and interplay between them [9,10]. Genome-wide scans
have been utilized in an attempt to identify multiple regions
simultaneously, called quantitative trait loci (QTLs), that
regulate different EAE phenotypes [7,8,11–18]. The effects of
several of these QTLs have subsequently been confirmed in
congenic strains and are now being subjected to positional
cloning [19–25].
A few successful demonstrations of positional cloning such
as CD36 in hypertension [26], Ncf-1 in arthritis [27], CTLA-4
in type 1 diabetes [28], and Fcgr3 in glomerulonephritis [29]
demonstrate that it is possible to identify genes underlying
QTLs. This endeavor has, however, proven to be considerably
more challenging than what was expected from experience
with monogenic diseases. The reasons lie in the intrinsic
complexity of the disease, primarily the modest effect of each
susceptibility gene, the incomplete genetic penetrance, clus-
tering of susceptibility genes, and complex gene–gene and
gene–environment interactions [24,30]. Genome-wide analy-
ses in F2 crosses using a number of different inbred rat strains
aimed (i) at addressing the issue of genetic heterogeneity and
detection of additional QTLs that will operate exclusively in
Table 1
An overview of the F2 crosses used to identify QTLs that regulate EAE
Cross Type Susceptible Resistant EAEa % EAE N b Nm
c Type d
1 F2 DA ACI MOG 19 188 166 Extreme
2 F2 DA BN WSC 39 285 195 Extreme
3 F2 LEW.AV1 PVG.AV1 MOG 71 185 222 Whole
a EAE was induced by immunization with recombinant MOG (1-125 aa) in
IFA (MOG) and whole spinal cord homogenate in CFA (WSC).
b Size of F2 population that was subjected to EAE induction.
c Number of microsatellite markers that was used to genotype the genome.
d F2 rats that were selected for genotyping were either rats that displayed
extreme phenotypes (extreme) or a whole F2 population (whole).
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duction and therefore confirmation of QTLs and reassure
likelihood of positional cloning and finally (iii) at identifying
common QTLs that segregate in different strain combinations,
which could give a basis for subsequent gene identification
with the aid of haplotype analysis. Although powerful,
genome-wide analyses depend on factors such as heritability,
size of F2 population, diversity between parental inbred
strains, and density of genetic markers, which are difficult to
predict a priori [31]. Consequently, F2 genome-wide scans in
EAE identified a number of QTLs that displayed modest
effects and many of them could not be reproduced with
certainty [6–8,17,32].
Ultimately, an efficient way to achieve these aims is to
combine the raw data obtained in the different crosses and
perform a combined-cross analysis. Whereas such and similarFig. 1. QTLs that regulate susceptibility to EAE detected in individual F2 crosses
imputation method are given on the y axis and chromosomal positions are given on
markers). Shared QTLs were detected using cross as an additive covariate (gray l
covariate (black line). Sharing is indicated by the lack of a significant difference betw
score difference <2.1). Horizontal solid and dashed lines indicate 0.05 and 0.63 sig
levels for significant linkage were 4.1 (ALL, F2 cross index as interactive covariate), 3
and 3.5 (LEW×PVG).analyses have been reported for MS [33–35], none has yet been
published for EAE. Recently, Li and colleagues published
analytical methods and their application of combined-cross
analysis of QTLs that regulate cholesterol levels in inbred mice
[36]. With the rat genome sequences completed, statistical tools
for QTL analysis developed, and data from previous F2 crosses,
we can now investigate the architecture of QTLs that regulate
rat autoimmune neuroinflammation in more detail by perfor-
ming combined-cross analysis. We here present the outcome of
combined-cross analysis on pooled data from three different F2
crosses [7,8,17] that we hope will motivate future comprehen-
sive efforts.
Results
Genome-wide analysis
We performed the analysis on combined data from three F2
crosses (Table 1) using affection status of rats as EAE
phenotype and the F2 cross as a covariate. Detailed lod score
plots and values are given in Fig. 1 and Table 2. Eight QTLs
that regulate susceptibility to EAE in rats were detected in the
three F2 crosses. Four significant QTLs (on chromosomes 1, 9,
13, and 17) and one suggestive QTL (on chromosome 15)
were detected when the cross covariate was analyzed as
interactive. Two significant (on chromosomes 1 and 9) and
five suggestive (on chromosomes 12, 14, 15, 17, and X) QTLs
were detected when the cross covariate was analyzed as
additive. It is interesting to note that most of the QTLs (onand after combined-cross analysis. The lod scores generated by the multiple
the x axis (small vertical lines represent positions of genotyped microsatellite
ine), whereas cross-specific QTLs were detected using cross as an interactive
een lod scores obtained using the cross as interactive and additive covariate (lod
nificance thresholds, respectively, generated with 1000 permutations. The 0.05
.1 (ALL, F2 cross index as additive covariate), 3.0 (DA×ACI), 3.1 (DA×BN),
Table 2
Summary of QTLs that regulate susceptibility to EAE detected in individual F2 crosses and after combined-cross analysis
Chr Single F2 crosses a, b Combined-cross analysis a
DA×ACI DA×BN LEW×PVG LODint
c LODadd
d p e Δ f
1 1.8*,† 3.0**,† 4.9 3.7 0.3 3.7
0–100 (100) 2–112 (110) 0–23 (23) 0–16 (16)
9 ‡ 5.4+ 5.6 5.4 0.9 3.7
2–64 (62) 0–50 (50) 0–47 (47)
12 2.1**,† † 1.9ns 1.9** 1 4.7
10–38 (28) 1–38 (37) 1–38 (37)
13 3.5† 3.9+,† 5.3 0.7ns 0.0003 3.0
47–58 (11) 39–106 (67) 25–106 (81)
14 1.9**,‡ 2.7ns 2.1** 0.6 3.8
5–88 (83) 5–88 (83) 5–88 (83)
15 1.3*,‡ †,‡ ‡ 3.2** 2.6** 0.6 4.0
33–85 (52) 10–100 (90) 10–105 (95) 10–105 (95)
17 1.6*,‡ 2.9**,† 4.3 2.6** 0.1 2.8
21–87 (66) 20–76 (56) 15–62 (47) 18–55 (37)
X ‡ 2.3**,‡ 2.4ns 2.3** 1 3.5
42–123 (81) 23–135 (112) 23–135 (112)
a Values represent lod scores, with 95% confidence intervals for QTL location in megabases, generated by bootstrapping, given below the lod score in italic (the size
of the 95% confidence interval is indicated in parentheses). Significance thresholds were generated with 1000 permutations (**, *, and ns indicate 0.63 cutoff, just
below 0.63 cutoff, and nonsignificant values, respectively).
b Significance thresholds were generated with 1000 permutations (+, †, and ‡ indicate significant, suggestive, and supportive QTL in the original F2 analysis).
c Combined-cross analysis performed using F2 cross index as interactive covariate (LODint).
d Combined-cross analysis performed using F2 cross index as additive covariate (LODadd).
e Significance of difference between lod scores generated using F2 cross index as interactive versus additive covariate (LODint vs LODadd). Significant values,
p<0.05, are for LOD difference >2.1.
f Difference between lod scores generated using single- and two-QTL model (difference in lod scores >4.5 is considered to be p<0.05).
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all three crosses or subset of crosses although most of them were
not identified after each individual F2 cross analysis (Fig. 1).
This sharing is indicated by the lack of significant difference
between lod scores obtained using the cross as interactive and
additive covariate, further in the text referred to as LODint and
LODadd, respectively. The most significant QTLs were analyzed
in detail.
EAE QTL on rat chromosome 1
The QTL on rat chromosome 1 displayed LODint and
LODadd of 4.9 and 3.7, respectively, in the vicinity of marker
D1Rat4 at 12 Mb (Fig. 2A). This QTL had previously
demonstrated evidence supporting linkage and suggestive
linkage in the (DA×BN)F2 cross and (LEW×PVG)F2,
respectively (Table 2). Lack of significant difference between
LODint and LODadd (p>0.5) indicates that this QTL is shared
between different F2 crosses (Table 2). This notion is further
supported by a dramatic reduction in the 95% confidence
interval from 100–110 to 16–23 Mb after combined-cross
analysis (Fig. 2A, Table 2). The DA/LEW strains share the
allelic variant of the underlying gene that predisposes for EAE,
whereas the ACI/BN/PVG strains share the allelic variant that
protects from EAE (Fig. 3A).
There is a possibility of an additional QTL on rat
chromosome 1, located around 100–120 Mb (Fig. 2A), that
would be specific for the LEW/PVG cross. However, our data
did not have sufficient power to resolve this QTL.Eae4 on rat chromosome 9
The QTL on the centromeric end of rat chromosome 9,
previously designated Eae4, was detected with the maximum
LODint and LODadd of 5.6 and 5.4, respectively, for marker
D9Rat40 at 9 Mb (Fig. 2B). Eae4 displayed significant linkage
in the (DA×BN)F2 cross, whereas there was no evidence for
linkage to EAE in the other two crosses, (DA×ACI)F2 and
(LEW×PVG)F2 (Table 2). Interestingly, there was no
difference between LODint and LODadd, suggesting that Eae4
is a shared QTL (Table 2). Closer inspection of the influence of
the peak marker on EAE in the (DA×BN)F2 cross as well as
markers with similar positions in two other F2 crosses suggests
an influence of genotype on phenotype that did not reach
statistical significance (Fig. 3B). We could therefore determine
the allelic state of the gene underlying Eae4 as follows: DA/
LEW as disease-promoting and ACI/BN/PVG as disease-
protecting. Furthermore, combined-cross analysis narrowed the
95% confidence interval from 62 Mb in the original cross to
47 Mb (Fig. 2B, Table 2).
Eae17—transgressive QTL on rat chromosome 13
One of the strongest QTLs was detected on rat chromosome
13 with LODint of 5.3 for marker D13Rat23 at 47 Mb. This
QTL, designated Eae17, has previously been detected in the
(DA×ACI)F2 and the (LEW×PVG)F2 crosses (Table 2).
Interestingly, analysis using cross as an additive covariate
resulted in LODadd of 0.7, with a significant difference between
Fig. 2. Significant and suggestive QTLs detected by combined-cross analysis of three F2 crosses. The lod scores generated by the multiple imputation method are given
on the y axis and chromosomal positions on the x axis. Shared QTLs were detected using cross as additive covariate (ALL ADD), whereas cross-specific QTLs were
detected using cross as interactive covariate (ALL INT). Sharing is indicated by the lack of a significant difference between lod scores obtained using the cross as
interactive and additive covariate (lod score difference <2.1). Horizontal dashed lines indicate significant and suggestive linkage at levels of 0.05 and 0.63,
respectively, generated with 1000 permutations. The 95% confidence intervals, generated by bootstrapping, are represented by horizontal gray bars.
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indicate that Eae17 is a cross-specific QTL. However, closer
inspection of allelic effects in the original (DA×ACI)F2 cross
revealed that this is an example of a transgressive QTL in the DA/
ACI strain combination, where an allele from the resistant ACI
strain predisposes for the disease (Fig. 3C). We recoded alleles
according to the effect on susceptibility and reanalyzed the data
(Fig. 4A). The difference between LODint of 4.4 and LODadd of
1.2 was still significant (p<0.005). This could indicate that there
are two QTLs in the Eae17 region, one that segregates in the DA/
ACI strain combination with the ACI allele being disease
predisposing and another that segregates in the LEW/PVG strain
combination with the LEWallele being disease predisposing. We
performed analysis on the combined data from (DA×ACI)F2
and (LEW×PVG)F2 crosses, omitting the (DA×BN)F2 cross
(Fig. 4B). There was still a significant difference between LODint
and LODadd of 4 (p<0.001). Furthermore, the possibility of
linked QTLs in the region, investigated by implementing a pair-
scan analysis, resulted in the lod score of 11.3 for the existence of
two QTLs at positions 38 and 48Mb. The difference between this
lod score and LODint is 4.6, which is just above the significance
level of 4.5. We might then conclude that there are two linked
QTLs, one that operates in DA/ACI and the other in LEW/PVGcombinations. This is further supported by the lack of reduction
in the 95% confidence interval (Table 2). However, we have to
be cautious in the interpretation, considering the allelic effect of
this region, ACI recessive, LEW dominant, and a tendency for
DA/BN heterozygous in the DA/ACI, LEW/PVG, and DA/BN
strain combination, respectively (Fig. 3C), and that our allele
coding in the combined-cross analysis cannot distinguish
different heterozygotes.
Eae19 on rat chromosome 15
Evidence for a QTL on rat chromosome 15 was detected with
LODint and LODadd of 3.2 and 2.6, respectively, for marker
D15Rat71 at 85 Mb (Fig. 2D). Evidence supporting this QTL,
designated Eae19, although not significant, came from all three
F2 crosses (Table 2). The DA/LEW rats share the allelic variant
of the underlying gene that predisposes for EAE, whereas ACI/
BN/PVG share the allelic variant that protects from EAE (Fig.
3D). There was however no reduction in 95% confidence
intervals, probably due to the modest effect of Eae19 (Fig. 2D,
Table 2).
Eae19 accounts for approximately 1–3% of phenotypic
variance depending on the F2 cross, representing a modest QTL
Fig. 3. Effects of QTL alleles on susceptibility to EAE. Mean EAE affection status (affected, 1; unaffected, 0) of rats±SEM is given on the y axis. Charts represent
influence of genotypes for the marker closest to the peak in the respective cross (position in Mb is given in the lower right corner) on the mean affection status, with
three possible genotype groups given on the x axis. Asterisks in the upper right corner indicate evidence for a QTL in the individual F2 crosses.
741M. Jagodic, T. Olsson / Genomics 88 (2006) 737–744as the majority of EAE QTLs. Simulation of F2 populations of
different sizes generated lod scores for Eae19 of 1.4±0.5, 1.6±
0.9, 2.4±0.3, 3.2±0.3, and 4.2±0.9 in data sets comprising
200, 400, 600, 800, and 1000 F2 rats, respectively. The
threshold values for significance, determined by permutation
analysis, were LOD≥3.2, LOD≥2.9, and LOD≥1.9 for 0.05,
0.1, and 0.63 significance levels, respectively. In populationsFig. 4. Transgressive Eae17 QTL on RNO13. The lod scores generated by the
multiple imputation method are given on the y axis and chromosomal positions
on the x axis. Shared QTLs were detected using the F2 cross index as additive
covariate (dashed line), whereas cross-specific QTLs were detected using the F2
cross index as interactive covariate (continuous line). Cross-specific QTLs are
indicated by significant difference (lod score difference >2.1) between these two
analyses. Analyses were performed on the combined data from (A) all three F2
crosses and (B) (DA×ACI)F2 and (LEW×PVG)F2 crosses. In the upper
graphs (“original codes”) DA/LEW was coded as 1 and ACI/BN/PVG as 2,
whereas in the lower graphs (“re-coded”) ACI/LEW was coded as 1 and DA/
PVG as 2. All heterozygotes were coded as 3.of 200 and 400 F2 rats, covering the most commonly utilized
population size span, lod scores for Eae19 were below any
evidence of linkage. In the population of 600 F2 rats Eae19
lod scores display some evidence of linkage but still below 0.1
levels. This modest QTL displayed significant linkage in
populations of 800 and 1000 F2 rats.
EAE QTL on rat chromosome 17
The QTL on rat chromosome 17 displayed significant
LODint and suggestive LODadd of 4.3 and 2.6, respectively, in
the vicinity of the marker D17Rat67 at 35 Mb (Fig. 2E).
Evidence for this QTL was detected in the previous (DA×BN)
F2 and (LEW×PVG)F2 crosses (Table 2). The difference
between LODint and LODadd, although not statistically
significant (p=0.1), might indicate that this QTL does not
segregate in the DA/ACI strain combination. Therefore, DA/
LEW share the allelic variant of the underlying gene that
predisposes for EAE at 35 Mb, whereas BN/PVG share the
allelic form that protects from EAE (Fig. 3E). Furthermore, a
shape of the lod curve detected in the (LEW×PVG)F2 cross
indicates a possibility of additional QTL around 65–75 Mb in
this strain combination (Fig. 2E).
Additional QTLs have been detected on chromosomes 12,
14, and X that have not been described in detail (Fig. 1, Table
2). Some indications of influences from chromosomes 5, 10,
and 19 that did not reach levels of suggestive linkage were
detected. However, a region on chromosome 5 (LODint=1.75)
was detected at the same position as Eaex in the (E3×DA)F2
cross [32]. This QTL displays the following allele distribution:
LEW/BN vs DA/PVG. Therefore the allele from the
susceptible DA strain confers protection from disease, which
742 M. Jagodic, T. Olsson / Genomics 88 (2006) 737–744is in accordance with the effect detected in the DA/E3 strain
combination [32].
Discussion
Combined-cross analysis of three F2 crosses in EAE, which
involved five inbred rat strains, resulted in the following main
conclusions: (i) many QTLs are shared between strains, that is,
they appear in different strain combinations, and are thus
reproduced by the combined-cross analysis; (ii) some QTLs are
specific for a certain cross, that is, they appear only in a specific
strain combination, reflecting genetic heterogeneity; and (iii)
combined-cross analysis enables the determination of the allelic
state of the QTL in particular strains and, in the case of shared
QTLs, reduces confidence intervals.
Eight QTLs that regulate susceptibility to EAE were
identified by combined-cross analysis. There were additional
influences from regions on chromosomes 5, 10, and 19 that did
not reach levels suggestive of linkage. Additional QTLs would
certainly have appeared if other EAE phenotypes, in particular
severity and chronicity, were analyzed. However, these
phenotypes are more difficult to standardize between the
three F2 crosses and we have, therefore, chosen to run our
analysis on a more robust phenotype, such as EAE affection
status.
We conclude that many shared QTLs were detected in the
combined-cross analysis, which had not reached significance in
each individual F2 cross. We believe that a main reason for this
is the number of individuals analyzed, which affects power.
Thus, the size of a single F2 population of 200–300 rats,
commonly used in analyses of EAE, is apparently not sufficient
to reproducibly detect multiple QTLs with modest effects such
as those that regulate EAE. An illustrative example is Eae19 on
chromosome 15, which was here detected as a suggestive QTL
in the combined cross comprising 658 F2 rats and previously
displayed only weak evidence for linkage in individual F2
crosses [7,8,17]. The influence of this QTL has independently
been confirmed by introducing the ACI allele on the DA
background in a congenic strain as well as in the DA/PVG
intercross [25], thus confirming the combined-cross analysis
data. A population size that allows detection of significant
linkage to Eae19, representing a true QTL of a modest effect, is
approaching 800 F2 rats. Detection of the majority of EAE
QTLs, which display influences similar to those of Eae19, will
therefore require populations of a minimum of 600 F2 rats, with
significant linkages occurring in 800 to 1000 F2 rats.
Combined-cross analysis may also detect new QTLs not
apparent in individual F2 crosses. Thus in the present analysis,
the regions on chromosomes 5 and 19 appeared with some
evidence of linkage, not at all apparent in our previous three
crosses. The relevance of these particular QTLs is supported by
their demonstration in an independent (E3×DA)F2 cross [32].
A further inherent complication in the analysis of different strain
combinations relates to genetic heterogeneity. Thus, there might
be additional QTLs on chromosomes 1 and 17 that would
segregate only in the LEW/PVG combination, reflecting
genetic heterogeneity, which is seen in human MS as well[37]. Consequently, these regions did not reach statistical
significance in the present combined-cross analysis. Together,
these findings strongly advise utilization of larger F2 crosses to
investigate genetic heterogeneity and to reproduce previously
identified QTLs. Importantly, shared QTLs indeed found in
combined-cross analysis demonstrate a crucial confirmation,
which in turn motivates further positional cloning attempts.
Meta-analysis performed on several complex human diseases
suggested a similar selection of the most promising QTLs for
further analysis [38].
There are a number of reasons, in addition to F2
population size and analyzed phenotype, responsible for the
failure of individual F2 crosses to detect certain QTLs. The
genomic coverage might explain the case of shared QTL on
chromosome 1 at 12 Mb that was detected in the (DA×BN)
F2 and the (LEW×PVG)F2 crosses [7,17]. The most
probable reason for failure of the (DA×ACI)F2 cross to
detect this QTL is the lack of marker coverage in this region
(first marker is at 41 Mb) [8]. Investigation of the effects of
genotypes at the first genotyped marker in (DA×ACI)F2
suggests a weak effect that might reflect even stronger
upstream effects, which unfortunately could not be deter-
mined due to the lack of genotyped markers in the region
(Fig. 3A). The differences in EAE induction protocols could
be the explanation for failure of the (DA×ACI)F2 and
(LEW×PVG)F2 crosses to detect Eae4 on rat chromosome
9, the strongest QTL detected in the (DA×BN)F2 cross [7].
The first two crosses were performed in EAE induced with
recombinant MOG in incomplete Freund's adjuvant (IFA),
whereas later, EAE was induced with whole spinal cord
homogenate in complete Freund's adjuvant. Recombinant
MOG/IFA induction might primarily involve other regions,
leaving just a small proportion of influence to Eae4. This is
supported by the influence of genotypes on phenotype that
did not reach statistical significance (Fig. 3B). A similar
effect has been demonstrated for pertussis toxin in murine
EAE [15]. Nevertheless, a possibility of an additional linked
gene or the third allelic variant can not be excluded.
Particularly interesting is the QTL on chromosome 13,
which displayed linkage in the (DA×ACI)F2 and
(LEW×PVG)F2 crosses [8,17], and combined-cross analysis
suggested that it might contain two linked cross-specific
QTLs. The first QTL, around 40 Mb, segregated in the DA/
ACI combination and represents an example of a transgres-
sive QTL, in which the allele from the resistant ACI strain
predisposes for disease in a recessive manner. The second
QTL, Eae17, around 50 Mb, segregated in the LEW/PVG
combination with the LEW allele predisposing for disease in a
dominant manner. However, we have to be cautious in the
interpretation of the data since there are several arguments
suggesting that Eae17 might also be a shared QTL: (1)
analysis of linked cross-specific QTLs displayed borderline
significance; (2) there is a different pattern of effect in
different strain combinations that could be explained by
background gene effect (ACI recessive, LEW dominant, and a
tendency for DA/BN heterosis), and coding for combined-
cross analysis could not distinguish different heterozygotes
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for cross-specific QTLs); and (3) some evidence of linkage
was detected in the vicinity of 50 Mb but not 40 Mb in the
7th and 10th generations of an intercross between DA/PVG,
suggesting that these two strains might share the same variant
at 40 Mb, whereas a QTL segregates between DA/PVG at
50 Mb, further supporting the possibility of two shared QTLs
(P. Stridh-Igo, T. Olsson, K. Becanovic, unpublished data).
The possibility of a third allelic variant, however, could not
be excluded. This emphasizes a number of factors that should
be taken into account when determining reproducible
linkages.
Haplotype mapping has proven to be a powerful approach
to map QTLs at an extremely high resolution both in mice [39]
and in rats [40]. A combined-cross analysis can determine the
allelic states on the basis of QTL effect in the individual
crosses. More importantly, it can resolve multiple linked QTLs.
These QTLs appear as a shared QTL, whereas they are distinct
closely situated cross-specific QTLs. The outcome of analysis
might be ambiguous in the case of QTLs that display very
weak effects or QTLs that display distinct allelic effect in
different crosses. However, parameters such as a significant
difference in the lod score between the model assuming
existence of linked QTLs versus the model assuming existence
of a single QTL, accompanied by a reduction in the confidence
interval, might assist in the resolution of linked QTLs.
Consequently, the correct allelic state could be determined
and the pattern of haplotype blocks in parental strains could be
combined with QTL mapping data to refine the region. This
information can significantly facilitate subsequent cloning of a
susceptibility gene and help in delineation of the key poly-
morphism [41].
In conclusion, this is the first combined-cross analysis on
data from F2 crosses in rat EAE. Our data demonstrate that a
large fraction of EAE QTLs appear to be shared among
different strain combinations and therefore reproduced by the
combined-cross analysis, which supports their further inves-
tigation. There was a lack of power in previously performed
F2 crosses, and larger populations in future studies together
with combined-cross analysis are recommended. Moreover,
application of combined-cross analysis provides instant
benefits by means of improved power, resolution, and
information on the allelic state of QTLs that can considerably
facilitate gene identification.
Materials and methods
Theoretical background and practical steps in performing combined-cross
analysis on several independent inbred line crosses have been described in
detail by Li and colleagues [36]. In this study, data from three F2 crosses,
summarized in Table 1, were combined and analyzed together. The genetic
map and positions of all markers used in the three crosses were implemented
from the rat genome sequence (http://www.ensembl.org/, version 29). The
analyzed EAE phenotype was affection status of each rat, which represents the
susceptibility to developing disease (defined as 1 for rats that developed EAE
or 0 for rats that remained healthy). The final outcome of this phenotype is in
fact binary; however, there is an underlying liability, a developing pathogenic
response, which behaves as a real quantitative trait and once it reaches a
threshold the disease ensues. The coherent correlation of affection status anddifferent severity phenotypes, as well as their linkage to the same genome
regions, demonstrated that these phenotypes are strongly dependent on each
other [42,43]. We have, therefore, chosen affection status as a robust,
representative disease phenotype because it can be accurately and objectively
determined in different crosses. Alleles were recoded based on the parental
phenotypes as follows: DA and LEW, which are susceptible strains, were
coded as 1, whereas ACI, BN, and PVG, which are resistant strains, were
coded as 3, and all heterozygotes were coded as 2. Genome-wide lod scores
were generated using both the multiple imputation method with 64 simulations
and the binary model [42,43]. Only data from the multiple imputation method
are shown. The method is particularly suitable for this type of analysis since it
simulates multiple versions of complete genotype information genome-wide
using information in the marker genotype while maintaining a considerable
speed of computation [43]. The binary model, applied because of the binary
nature of the analyzed EAE phenotype, generated comparable results (data not
shown). For each F2 cross combination, an indicator variable (cross) was
generated and included in the analysis as a covariate. To detect a shared QTL,
i.e., a QTL that occurs in all of the crosses, the cross variable was used as an
additive covariate. To detect a cross-specific QTL, i.e., a QTL that occurs in a
subset of crosses, the cross variable was used as an interactive covariate to
account for a QTL-by-cross interaction. A difference in the lod score between
the analysis for a shared (LODadd) and that for a cross-specific QTL (LODint)
indicates that the QTL is cross-specific. The p value for the statistically
significant difference is computed from χ2=2ln(10LOD) with 4 degrees of
freedom and corresponds to LODint−LODadd>2.1 [36]. To detect linked
QTLs, i.e., closely situated QTLs, a pair-scan analysis was performed with the
cross as an interactive covariate. The difference between the lod scores
generated from the cross-specific QTL analysis (LODint) and the pair-scan
analysis bigger than 4.5 indicates linked QTLs in the region [36]. Significance
levels, generated by 1000 permutations, were defined as 0.05 and 0.63 for
significant and suggestive linkage, respectively [36]. A confidence interval of
95% for linkage was defined by bootstrapping (n=1000). All calculations were
performed by GNU R.2.0.1 with the R/qtl package version 0.98-55 [44].
From the combined-cross data set of 658 F2 rats, five data sets of 200, 400,
600, 800, and 1000 rats were randomly generated in 10 replicates using a
computer-assisted selection. Genome-wide lod scores were generated using the
multiple imputation method with 64 simulations and the F2 cross as an additive
covariate for each replicate, and significance levels were generated using 500
permutations for each data set. Average lod scores and standard deviations were
derived for each data set.Acknowledgments
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